Bridgepoint Regulatory News (BPT)

Bridgepoint Group plc ("Bridgepoint" or the "Company")

Appointment of John Dionne and Michelle Scrimgeour as Independent Non-Executive Directors

14 April 2025

Bridgepoint is pleased to announce the appointment of John Dionne and Michelle Scrimgeour as independent non-executive directors with effect from 1 July 2025. 

Until he retired as a Senior Managing Director of Blackstone, John served as Global Head of the Private Equity Business Development and Investor Relations groups. He first joined Blackstone as the Founder and Chief Investment Officer of the Blackstone Distressed Securities Fund. Earlier in his career, John was a Partner and Portfolio Manager for Bennett Restructuring Funds, a Partner at Saugatuck Capital and a Director of Corporate Development for a predecessor of Thermo Fisher Scientific. He began his career at Price Waterhouse as a public accountant.

He is a Senior Lecturer of Business Administration at the Harvard Business School.

Michelle served as Chief Executive Officer of Legal & General Investment Management from July 2019 to December 2024. Before joining Legal & General, Michelle was Chief Executive Officer, EMEA, at Columbia Threadneedle Investments and was a member of the Executive Leadership Team of Ameriprise Financial. Earlier in her career she was Chief Risk Officer at M&G Investments and a Director of M&G Group Limited, which she joined in 2012 after a successful career at BlackRock. Michelle has served as Deputy Chair of the Investment Association, Chair of the Technology Working Group of the UK Government's Asset Management Taskforce and was a member of the FCA's Practitioner Panel. 

On appointment, Michelle will become the Chair of the Audit and Risk Committee, and John will become a member of the Audit and Risk Committee. 

Commenting on the appointments, Tim Score, Chair, said:

"I am delighted to welcome John and Michelle to the Board. Following a thorough appointment process, we are excited to have found two great candidates with extensive experience in asset management. Their respective experiences will be invaluable to the Bridgepoint Group as it continues to implement the strategy outlined at the Capital Markets Day in October 2024."

ENQUIRIES

Bridgepoint

Finsbury Glover Hering (Public Relations Adviser to Bridgepoint)

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

Anna Tabor / +44 20 7251 3801 / +44 7584 593 926

Bridgepoint-LON@fgsglobal.com 

The following information is disclosed in accordance with UKLR 6.4.8 in respect of John Dionne and Michelle Scrimgeour:

Further information relating to John Dionne

Current publicly quoted company directorships

Previous publicly quoted company directorships

Additional roles

Through John Dionne's activities as an institutionally-backed investor in the securities of companies in or near bankruptcy, he has held directorships in certain companies shortly before bankruptcy, or after its commencement. In addition to his directorship of Sequential Brands Group, Inc prior to its bankruptcy, as referred to above, he was appointed as a director of Crown Finance, US Inc and 65 of its subsidiaries following their filing for bankruptcy protection.

Further information relating to Michelle Scrimgeour

Michelle Scrimgeour was previously a director of Legal & General Group plc. 

There are no other disclosures to make pursuant to UKLR 6.4.8 in respect of either John Dionne or Michelle Scrimgeour.

Issued by Bridgepoint Group plc

LEI: 213800KFNMVI8PDZX472

Registered in England and Wales with registration number 11443992

Registered office: 5 Marble Arch, London, W1H 7EJ